EASL–EORTC Clinical Practice Guidelines (CPG) on the manage- ment of hepatocellular carcinoma (HCC) deﬁne the use of surveil- lance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer. These guidelines update the recommendations reported by the EASL panel of experts in HCC published in 2001 . Several clinical and scien- tiﬁc advances have occurred during the past decade and, thus, a modern version of the document is urgently needed. The purpose of this document is to assist physicians, patients, health-care providers, and health-policy makers from Europe and worldwide in the decision-making process according to evidence- based data.
The clinical practice guidelines below will give advice for up to date management of patients with HCC as well as providing an in-depth review of all the relevant data leading to the conclusions.